Who owns TAYSHA GENE THERAPIES INC?
- Ticker: TSHA
- CUSIP Number: 877619106
Tip: Access positions for across all investors
Analyze quarterly positions in Taysha Gene Therapies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Taysha Gene Therapies stock
Who bought or sold TAYSHA GENE THERAPIES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 20M | $58M | -18% | Mar 2024 |
|
| RA Capital Management | 11M | $31M | -41% | Mar 2024 |
|
| VR Adviser | 9.0M | $26M | -14% | Mar 2024 |
|
| Vanguard Group | 5.9M | $17M | -4% | Mar 2024 |
|
| Morgan Stanley | 5.2M | $15M | 2904% | Mar 2024 |
|
| venBio Select Advisor | 4.4M | $7.7M | 11% | Dec 2023 |
|
| Baker Bros. Advisors | 4.0M | $12M | 0% | Mar 2024 |
|
| Artal Group | 3.7M | $11M | 1% | Mar 2024 |
|
| Millennium Management | 3.3M | $9.4M | -4% | Mar 2024 |
|
| Octagon Capital Advisors | 3.0M | $8.7M | 100% | Mar 2024 |
|
| BlackRock | 2.6M | $7.5M | 247% | Mar 2024 |
|
| Damian Sousa | 1.8M | $5.1M | 100% | Mar 2024 |
|
| Cowen And Company | 1.6M | $4.4M | 100% | Mar 2024 |
|
| Susquehanna International | 1.3M | $3.8M | 314% | Mar 2024 |
|
| Point72 Asset Management | 1.1M | $3.2M | -59% | Mar 2024 |
|
| T. Rowe Price Associates | 1.1M | $3.2M | -10% | Mar 2024 |
|
| Qube Research & Technologies | 1.1M | $3.1M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 1.1M | $3.0M | 1169% | Mar 2024 |
|
| Marshall Wace | 1.0M | $3.0M | 100% | Mar 2024 |
|
| Geode Capital Management | 1.0M | $2.9M | 121% | Mar 2024 |
|
| Soleus Capital Management | 925k | $2.7M | 100% | Mar 2024 |
|
| Palo Alto Investors | 811k | $2.3M | 53% | Mar 2024 |
|
| Sands Capital Ventures | 725k | $2.1M | 0% | Mar 2024 |
|
| Quantum Private Wealth | 699k | $2.0M | 9% | Mar 2024 |
|
| Alphabet | 641k | $1.8M | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 553k | $1.6M | -51% | Mar 2024 |
|
| Hrt Financial | 415k | $1.2M | 100% | Mar 2024 |
|
| Kovitz Investment Group Partners | 278k | $797k | 0% | Mar 2024 |
|
| Citigroup | 255k | $732k | -18% | Mar 2024 |
|
| Marathon Trading Investment Management | 224k | $643k | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 220k | $631k | -85% | Mar 2024 |
|
| Squarepoint Ops | 214k | $614k | 237% | Mar 2024 |
|
| Northern Trust | 211k | $607k | 219% | Mar 2024 |
|
| UBS Group | 189k | $543k | 4701% | Mar 2024 |
|
| Balyasny Asset Management | 189k | $542k | 100% | Mar 2024 |
|
| Point72 Asia | 181k | $520k | 100% | Mar 2024 |
|
| TD Asset Management | 176k | $504k | 0% | Mar 2024 |
|
| Brevan Howard Capital Management | 173k | $496k | 100% | Mar 2024 |
|
| Laurion Capital Management | 164k | $471k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 161k | $462k | 233% | Mar 2024 |
|
| Diametric Capital | 154k | $441k | -80% | Mar 2024 |
|
| Bank of America Corporation | 126k | $361k | 3% | Mar 2024 |
|
| Chicago Partners Investment | 125k | $317k | -7% | Mar 2024 |
|
| Two Sigma Investments | 122k | $349k | -11% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 112k | $323k | 218% | Mar 2024 |
|
| ExodusPoint Capital Management | 112k | $322k | 100% | Mar 2024 |
|
| Engineers Gate Manager | 111k | $319k | 100% | Mar 2024 |
|
| Y-Intercept | 97k | $279k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 94k | $269k | 157% | Mar 2024 |
|
| Citadel Advisors | 74k | $211k | -97% | Mar 2024 |
|
| Gts Securities | 61k | $176k | 100% | Mar 2024 |
|
| Jane Street | 59k | $169k | 39% | Mar 2024 |
|
| Springbok Capital Management | 56k | $160k | -77% | Mar 2024 |
|
| Charles Schwab Investment Management | 52k | $148k | 219% | Mar 2024 |
|
| Leucadia National Corporation | 48k | $138k | 100% | Mar 2024 |
|
| Dynamic Advisors Solutions | 45k | $129k | 0% | Mar 2024 |
|
| Williams & Novak | 45k | $80k | 0% | Mar 2024 |
|
| ADAR1 Capital Management | 44k | $125k | -79% | Mar 2024 |
|
| LPL Financial | 42k | $121k | -26% | Mar 2024 |
|
| XTX Topco | 41k | $118k | 100% | Mar 2024 |
|
| China Universal Asset Management | 36k | $103k | 66% | Mar 2024 |
|
| LMR Partners | 33k | $93k | 100% | Mar 2024 |
|
| CTC Alternative Strategies | 30k | $86k | 100% | Mar 2024 |
|
| Polymer Capital Management | 28k | $79k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 27k | $78k | 2% | Mar 2024 |
|
| Acadian Asset Management | 27k | $75k | 100% | Mar 2024 |
|
| Cannon Global Investment Management | 24k | $70k | 100% | Mar 2024 |
|
| Tower Research Capital | 24k | $69k | 100% | Mar 2024 |
|
| Lee Financial | 20k | $35k | 0% | Dec 2023 |
|
| Us Bancorp | 18k | $51k | 100% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 17k | $50k | 100% | Mar 2024 |
|
| Victory Capital Management | 17k | $49k | 8% | Mar 2024 |
|
| Howard Capital Management | 14k | $41k | 0% | Mar 2024 |
|
| ProShare Advisors | 13k | $38k | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 13k | $37k | 100% | Mar 2024 |
|
| TradeLink Capital | 11k | $32k | 100% | Mar 2024 |
|
| Twinbeech Capital | 10k | $29k | 100% | Mar 2024 |
|
| Symmetry Investments | 10k | $29k | 100% | Mar 2024 |
|
| Capital Investment Advisors | 10k | $29k | 0% | Mar 2024 |
|
| Quarry | 10k | $29k | 25% | Mar 2024 |
|
| Lazard Asset Management | 8.8k | $0 | 100% | Dec 2023 |
|
| Wells Fargo & Company | 7.4k | $21k | 0% | Mar 2024 |
|
| Headlands Technologies | 2.3k | $6.6k | 100% | Mar 2024 |
|
| Hanson McClain Advisors | 1.0k | $2.9k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 691.00 | $2.0k | 100% | Mar 2024 |
|
| Aquatic Capital Management | 400.00 | $1.1k | 100% | Mar 2024 |
|
| Morton Brown Family Wealth | 260.00 | $745.992000 | 0% | Mar 2024 |
|
| Riggs Asset Managment | 198.00 | $568.992600 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 134.00 | $387.005400 | 0% | Mar 2024 |
|
| Capital Advisors | 79.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Taysha Gene Therapies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Exome Asset Management | Dec 2023 | 693k | $1.2M |
| Eudaimonia Asset Management | Sep 2023 | 335k | $1.1M |
| Monaco Asset Management SAM | Dec 2023 | 295k | $522k |
| Polar Securities | Dec 2023 | 187k | $331k |
| Bridgeway Capital Management | Sep 2023 | 156k | $494k |
| Verition Fund Management | Sep 2023 | 85k | $269k |
| Bank of New York Mellon | Dec 2023 | 58k | $103k |
| Redwood Wealth Management Group | Dec 2023 | 43k | $75k |
| Graham Capital Management | Dec 2023 | 29k | $50k |
| Virtu Financial | Dec 2023 | 26k | $46k |
| Dynamic Technology Lab Private | Dec 2023 | 17k | $31k |
| Two Sigma Securities | Dec 2023 | 17k | $30k |
| Darren Munn | Dec 2023 | 11k | $20k |
| Royal Capital Wealth Management | Dec 2023 | 11k | $19k |
| Group One Trading | Sep 2023 | 5.6k | $18k |